A Community HIE-based Hospital Readmission Risk Prediction & Notification System
A Community HIE-based Hospital Readmission Risk Prediction & Notification System
批准号:
8737244
负责人:
Hadi Kharrazi
金额:
$15.22万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-30 至 2015-09-29
中文摘要
描述(由申请人提供):医院占美国医疗保健支出的近1万亿美元(约30%)。预防可避免的再入院被认为是减少医疗保健浪费的一个关键机会。大约18%的患者在30天内再次入院。据估计,近14%的医疗保险再入院-每年花费120亿美元-是可以预防的。尽管有以医院为中心的干预措施,
在过去的十年里稳步增长。门诊护理是减少再入院的必要手段。缺乏及时的初级保健医生(PCP)随访的患者再次入院的可能性增加了10倍。大约75%的出院摘要从未被PCP收到,50%的重新入院的医疗保险患者从未接受过随访。一个集成的医疗IT系统(例如,健康信息交流)可以增加PCP参与减少可避免的再入院。HIE可以有效地协调医院和PCP之间的护理,从而提高后续护理的准确性和可靠性。截至2012年,马里兰州的HIE(称为“CRISP”)收集了约400万名独特患者的实时数据,其中包括25万名已被400多名PCP明确登记的患者,这些患者使用CRISP的遭遇通知系统(ENS)进行特殊的跨实践监测。ENS通知参与提供者再入院和其他前哨事件。报告系统缺乏任何可操作的工具来“预测性地”识别患者的再入院风险。这项研究的活动将大大催化马里兰州医院和PCP社区的重点和规划准备,以避免再入院的先进阶段。马里兰州的大多数医院都没有支付所有再入院,由于国家的所有付款人委员会。所有的出院团队都经过特别培训,几乎所有的PCP现在都是先进的以病人为中心的医疗之家(PCMH)模式的一部分。该项目将基于约翰霍普金斯ACG(调整后的临床组,以前的门诊护理组),这是在开发和测试预测模型的国家最先进的之一。ACG已经在全国和其他15个国家使用了20年,并应用于6000多万患者,以帮助预测使用索赔和管理数据的各种医疗保健事件。虽然再入院风险预测模型(RRPM)是非常常见的事后使用健康计划索赔和医院管理数据库,他们很少利用HIE数据进行推导或验证。在这项探索性研究中,目标1是根据CRISP覆盖的人群开发和评价RRPM,以实时计算从马里兰州医院出院的每位患者的风险评分。目标2将通过迭代增强过程测试RRPM的准确性,该过程将整合非HIE数据源,以探索最有价值的未来数据源(即将推出,但尚未提供给CRISP);并在CCBC(新月市灯塔社区)测试CRISP的RRPM的普遍性。最后,在目标3中,RRPM通知系统将原型化并集成到CRISP的ENS中。将进行定性研究,以评估HIE衍生和交付的RRPM在参与PCP中的潜在有效性和可用性。
英文摘要
DESCRIPTION (provided by applicant): Hospitals account for nearly $1 trillion (~30%) of US health care spending. Preventing avoidable hospital readmissions is considered a key opportunity for reducing waste in health care. Around 18% of patients are readmitted to hospitals within 30 days. It is estimated that almost 14% of Medicare readmissions - costing $12 billion annually - are preventable. Despite hospital-centric interventions 'avoidable' readmissions
have increased steadily over the last decade. Ambulatory care is integral to reducing hospital readmissions. Patients lacking timely Primary care physician (PCP) follow ups are 10 times more likely to be readmitted. Around 75% of discharge-summaries are never received by PCPs and 50% of readmitted Medicare patients never had a follow up office visit. An integrated health IT system (e.g., a health information exchange) can increase PCP engagement in reducing avoidable readmissions. HIEs can efficiently coordinate care between hospitals and PCPs thus improving the promptness and reliability of follow-up care. As of 2012, Maryland's HIE (known as 'CRISP') collects real-time data of ~4 million unique patients, including 250k patients that have been explicitly registered by more than 400 PCPs for special cross-practice monitoring using CRISP's Encounter Notification System (ENS). ENS notifies participating providers of readmission and other sentinel events. The reporting system lacks any actionable tool to 'predictively' identify the patient's risk of readmission. The activities of this research will be significantly catalyzed by Maryland hospital and PCP community's advanced stage of focus and programmatic readiness to avoid readmission. Most hospitals in Maryland are not paid for all readmissions due to state's all-payer commission. All hospital discharge teams are especially trained and virtually all PCPs in the state are now part of an advanced patient centered care medical home (PCMH) model. The project will be based within The Johns Hopkins ACGs (adjusted clinical groups, formerly ambulatory care groups) that is one of the most advanced in the nation in developing and testing predictive models. ACG has been used for two decades across the nation and in 15 other countries, and applied to 60+ million patients to help predict various healthcare events using claims and admin data. While readmission risk predictive models (RRPM) are very common post-facto using health plan claims and hospital administrative databases, they have rarely utilized HIE data for derivation or validation. In this exploratory research, Aim 1 is to develop and evaluate an RRPM based on the population covered by CRISP to calculate a risk score for each patient discharged from Maryland hospitals in real-time. Aim 2 will be to test the RRPM's accuracy through an iterative enhancing process that will integrate non-HIE data sources to explore the most valuable future data sources (soon to be, but not yet available to CRISP); and, to test the generalizability of CRISP's RRPM at CCBC (Crescent City Beacon Community). Finally, in Aim 3 the RRPM notification system will be prototyped and integrated into CRISP's ENS. A qualitative study will be conducted to evaluate the potential effectiveness and usability of the HIE-derived-and-delivered RRPM among participating PCPs.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Advancing Maryland's Statewide Suicide Data Warehouse to Improve Individual and Population-level Mortality Prediction and Prevention
-
批准号:10693176
-
项目类别:
-
资助金额:$77.99万
-
财政年份:2020
-
负责人:Hadi Kharrazi
-
依托单位:
Advancing Maryland's Statewide Suicide Data Warehouse to Improve Individual and Population-level Mortality Prediction and Prevention
-
批准号:10435427
-
项目类别:
-
资助金额:$79.16万
-
财政年份:2020
-
负责人:Hadi Kharrazi
-
依托单位:
Advancing Maryland's Statewide Suicide Data Warehouse to Improve Individual and Population-level Mortality Prediction and Prevention
-
批准号:10263277
-
项目类别:
-
资助金额:$79.94万
-
财政年份:2020
-
负责人:Hadi Kharrazi
-
依托单位:
A Community HIE-based Hospital Readmission Risk Prediction & Notification System
-
批准号:8620097
-
项目类别:
-
资助金额:$14.76万
-
财政年份:2013
-
负责人:Hadi Kharrazi
-
依托单位:
Clinical Knowledge Hub - Conceptual Integration of Rules, Data Sets, and Queries
-
批准号:7816793
-
项目类别:
-
资助金额:$24.12万
-
财政年份:2009
-
负责人:Hadi Kharrazi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
PTBP-1调控星形胶质细胞转分化介导UCMSC-Exos改善MIA-HIE机制的研究
-
批准号:82301549
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:矫阳
-
依托单位:
内质网应激对HIE脑内AQP4去极化的影响和机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:黄娟
-
依托单位:
各向异性精细储层的井间电磁法HIE-FDTD正演
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:方思南
-
依托单位:
miR-30b/USP14 轴通过非Pink1/Parkin 途径调控线粒体自噬参与HIE 进展的机制研究
-
批准号:2022JJ30967
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:王霞
-
依托单位:
扩展宽松条件稳定HIE-FDTD算法机理及数值特性研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:孔永丹
-
依托单位:
H2S 通过JAK2/STAT3/小胶质细胞极化途径抑制新生儿HIE
-
批准号:2021JJ70036
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:刘剑锋
-
依托单位:
新生儿HIE发病及防治中AQPs调控的分子机制研究
-
批准号:81070539
-
项目类别:面上项目
-
资助金额:10.0万元
-
批准年份:2010
-
负责人:刘俐
-
依托单位:
基于人工神经网络的新生儿HIE早期诊断系统的研究
-
批准号:30772342
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2007
-
负责人:刘俐
-
依托单位: